1.000GBp-2.44%Mkt Cap: 17.26M GBpP/E: —Last update: 2026-05-13
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The co…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)0.01
PEG—
P/B—
P/S14.70
EV/EBITDA-2.08
EV/Revenue9.52
EPS (TTM)-0.01
EPS (Forward)2.10
Cash Flow & Leverage
FCF Yield-11.80%
FCF Margin-173.52%
Operating CF-5.14M GBp
CapEx (TTM)23.00K GBp
Net Debt/EBITDA-0.02
Net Debt113.00K GBp
Technical
SMA 500.9852 (+1.5%)
SMA 2000.8492 (+17.8%)
Beta0.92
S&P 52W Chg24.23%
Avg Vol (30d)6.79M
Avg Vol (10d)13.87M
Technical Indicators
RSI (14)52.0
MACD0.0135
MACD Signal-0.0004
MACD Hist.+0.0139
BB Upper1.079 GBp
BB Middle0.9677 GBp
BB Lower0.8566 GBp
BB Width22.95%
ATR (14)0.1210 GBp
Vol Ratio (20d)0.77x
52W Range
0.190048% of range1.875
52W High1.875 GBp
52W Low0.1900 GBp
Profitability
Gross Margin-283.99%
EBITDA Margin0.00%
Profit Margin-684.69%
Oper. Margin-459.47%
ROE-363.77%
ROA-185.83%
Revenue Growth62.90%
Earnings Growth—
Balance Sheet
Debt/Equity0.00
Current Ratio0.99
Quick Ratio0.78
Book Value/Sh0.0000 GBp
Cash/Share0.0000 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.1.61B
Float567.56M
Insiders63.18%
Institutions1.33%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap17.26M GBp
Enterprise Value11.18M GBp
Revenue (TTM)1.17M GBp
Gross Profit-3.33M GBp
Net Income (TTM)-5.23M GBp
Revenue/Share0.0020 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees43
Last Price1.000 GBp
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—